Drug profile · INN
strontium chloride sr-89
METASTRON
strontium chloride sr-89 (METASTRON) is a unknown. Route of administration: injection. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — strontium chloride sr-89
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
strontium chloride sr-89 (METASTRON) is a unknown. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN strontium chloride sr-89
Brand METASTRON
Mechanism Unknown
Route INJECTION
Formulation INJECTABLE
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is strontium chloride sr-89?
strontium chloride sr-89 (METASTRON) is a unknown. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for strontium chloride sr-89?
METASTRON is a marketed brand name for strontium chloride sr-89. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of strontium chloride sr-89?
strontium chloride sr-89 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.